Boston, Mar 10 (PTI) US scientists have identified a protein in saliva (histatin-5) that protects the body from traveller’s diarrhoea.Also Read - US President Joe Biden Plan Seeks to Expand Education, From Pre-K to College
The finding, published in the Journal of Infectious Diseases, may lead to the development of new preventive therapies for the disease. Also Read - US Has Enough COVID-19 Vaccines For Boosters, Kid's Shots
Traveller’s diarrhoea is an inconvenience to many in the US, but worldwide it can be deadly. It produces a watery diarrhoea, which can cause life-threatening dehydration in infants or other vulnerable populations in endemic countries. Also Read - PM Modi Clocks 20 Meetings in His 65-hour Stay in US
With more than one billion cases each year, hundreds of thousands of deaths can be attributed to this bacterial disease which is caused by enterotoxigenic Escherichia coli (ETEC), invading the small intestine using arm-like structures called “pili”, according to the study.
The researchers exposed miniature human small intestines that they were able to grow in a dish (organoids) to the bacteria ETEC in the presence and absence of the protein histatin-5.
When examined under the microscope, significantly fewer bacteria were able to attach to the tissue in the presence of histatin-5.
“We found that the protein histatin-5 present in human saliva stiffens the pili of ETEC, preventing the bacteria from effectively adhering to the small intestine,” said Esther Bullitt from Boston University School of Medicine (BUSM) in the US “If they can’t attach, they simply can’t cause disease,” Bullitt said.
This new finding opens up the possibility that other salivary proteins might exist which protect against many other diseases, including infectious gastritis, food poisoning or even pneumonia.
“We believe that our data represent the first example of a new paradigm in innate immunity: the contributions of salivary components to preventing infection,” Bullitt said.
“This research opens an untapped avenue for prevention of enteric infectious diseases through the targeted use of naturally occurring components of saliva,” Bullitt added.
This is published unedited from the PTI feed.